Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Resource Stocks Drag FTSE As Brent Rally Stalls

Mon, 25th Apr 2016 11:00

LONDON (Alliance News) - Shares in London were mixed Monday, with the heavyweight resource sector dragging on the FTSE 100, as investors await this week's monetary policy decisions from the US Federal Reserve and the Bank of Japan.

The FTSE 100 was down 0.2%, or 14.54 points, at 6,295.90 at midday. The blue-chip index is heading toward a third consecutive session in the red, following the 2016 high reached last week. It touched a peak of 6,427.32 on Thursday, its highest level since early December, but ended lower that day, as well as on Friday.

The FTSE 250 index of mid-caps was up 0.4% at 16,936.17 and the AIM All-Share was up 0.1% at 731.98.

"Equity markets have made a poor start to the week, still struggling to hold onto recent gains as bullish sentiment wanes and profit-taking continues ahead of central bank updates from the Fed and the BoJ," said Accendo Markets head of research Mike van Dulken.

The BoJ will announce its decision on Thursday, but before that the Fed's two-day monetary policy meeting is scheduled to finish on Wednesday.

Regarding the Fed, UBS analyst Drew Matus said the Swiss bank sees more "hawks", more dovish "doves" and a growing split even among members the bank would group as "neutral".

"The growing divisions are unlikely to drive policy decisions. However, they do suggest continued challenges to Fed communications as fewer members are likely to be giving a consensus view that would reflect the most likely course of action," said Matus.

Stocks in New York were expected to open lower, with the Dow 30, the S&P 500 and the Nasdaq 100 indices all pointed down 0.1%.

In the US corporate calendar, oil field services company Halliburton, private equity firm KKR and printer and copier maker Xerox release first-quarter updates ahead of the Wall Street open.

Still in the economic calendar, US new home sales are at 1500 BST, and the Dallas Federal Reserve manufacturing business index is at 1530 BST.

The FTSE 350 Mining sector index was by far the worst performing sector index in London, down 3.6%. The index had supported the FTSE 100 rally since the start of 2016, having reached its highest level since August 2015. However, the recent rally in miners appears to be running out of steam, accumulating three consecutive sessions of losses.

In the FTSE 100, Anglo American was down 6.1%, BHP Billiton down 4.8% and Rio Tinto down 3.1%. In the FTSE 250, Vedanta Resources was down 4.5%.

Vedanta's Cairn India subsidiary late Friday said its fourth-quarter net loss widened year on year, and it swung to a loss for the full financial year ended March 31. Vedanta holds a 59.8% stake in Cairn India.

Oil stocks also were among the biggest blue-chip decliners, with BP down 1.9% and Royal Dutch Shell 'A' shares down 1.8%.

Oil producers have benefited from an increase in crude prices, with Brent having recovered strongly from the multi-year lows around USD27 touched in January. However, the North Sea benchmark was taking taking a break from that rally Monday, with Brent standing at USD44.67 a barrel at midday in London, lower than the USD45.56 a barrel at the London equities close on Friday.

Among individual stocks in the FTSE 100, Imperial Brands, formerly Imperial Tobacco, was attracting investors attention following an upgrade to Buy from Neutral by Goldman Sachs. The stock was at the top of the blue-chip index, up 3.5%.

Meanwhile, Ted Baker was the best performer in the FTSE 250, up 5.4% also benefiting from a broker upgrade. Jefferies lifted its recommendation on the fashion retailer to Buy from Hold.

Mid-cap science and technology development group Allied Minds was the worst performer, down 7.2%. The company reported a widened pretax loss in what it called a "successful" 2015, as it increased investment in creating four new businesses and developing its existing businesses towards commercialisation.

It reported a pretax loss of USD98.0 million for 2015, widened from USD57.7 million in 2014, mostly as a result of higher selling, general and administrative expenses, and a big step up in research and development costs. Allied Minds said its group subsidiary ownership adjusted value, a key metric for the company, rose to USD535.8 million as at the end of 2015 from USD488.0 million at the end of 2014.

In Main Market, marketing services company St Ives was down 45% after saying it expects its underling pretax profit for its current financial year to be "materially below" its current expectations, and warned the following year would also be hit.

St Ives said its trading overall in the eight months to the beginning of April had continued to be "broadly in line" with its expectations, with revenue up 5% compared to the previous year. However, its outlook for the final quarter to end-July and following financial year has deteriorated. Global economic uncertainty has led to significant projects being deferred or cancelled, the group said.

European indices also were lower, with the CAC 40 in Paris down 0.5% and the DAX 30 in Frankfurt down 0.7%.

German business sentiment weakened slightly in April, survey results from the Ifo Institute showed. The Ifo Business Climate indicator dropped to 106.6 in April, while economists expected it to rise to 107.0 from the score of 106.7 in March. The current situation measure of the survey slid to 113.2 from 113.8. Economists had expected the score to remain at 113.8. Meanwhile, the expectations index of the survey rose to 100.4 in April from 100 in March. It was forecast to rise to 100.6.

In Asia on Monday, Tokyo's Nikkei 225 index closed down 0.8%, as did the Hang Seng in Hong Kong, whilst the Shanghai Composite slipped 0.4%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2016 08:30

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Read more
29 Sep 2016 08:12

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Read more
25 Aug 2016 08:05

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Read more
22 Aug 2016 07:07

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Read more
1 Aug 2016 08:12

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

Read more
13 Jun 2016 16:35

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

Read more
27 May 2016 15:30

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Read more
25 May 2016 10:04

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Read more
25 May 2016 07:08

Allied Minds Approves USD15 Million Funding For Allied-Bristol

Read more
19 May 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more
13 May 2016 11:42

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

Read more
26 Apr 2016 09:30

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Read more
26 Apr 2016 08:47

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Read more
26 Apr 2016 06:50

Allied Minds Secures USD80 Million Commitments For Drug Development

Read more
25 Apr 2016 14:07

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.